News Search Results
Nov 19, 2025, 12:20 ET NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Nov 19, 2025, 12:05 ET Elizabeth Gardon Joins Rubin Rudman's Litigation Group
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Nov 19, 2025, 11:33 ET NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Nov 19, 2025, 11:08 ET Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
DALLAS, Nov. 19, 2025 /PRNewswire/ -- Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth
More news about: Dialectic Therapeutics, Inc.
Nov 19, 2025, 10:20 ET Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure
MONTREAL, Nov. 19, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic
More news about: Thryv Therapeutics Inc.
Nov 19, 2025, 10:16 ET Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research
market, primarily due to increasing cancer cases and rising awareness of personalized treatments. An article published by the National Center for Biotechnology Information (NCBI) in 2023 estimated that the incidence of cancer cases is expected to rise by 12.8% in 2025 compared to 2020. Drivers include a
More news about: Allied Market Research
Nov 19, 2025, 10:13 ET Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
SAN CARLOS, Calif., Nov. 19, 2025 /PRNewswire/ -- Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the nomination of APRTX-001 as its
More news about: Aperture Therapeutics
Nov 19, 2025, 10:10 ET Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion Revenue by 2033 - Grand View Research, Inc.
North America dominated the market in 2024 with a 38.57% share, primarily attributed to the significant growth of its pharmaceutical and biotechnology industries. This leading position is further reinforced by increasing approvals for cell culture-based vaccines, a rising incidence of diseases
More news about: Grand View Research, Inc.
Nov 19, 2025, 09:17 ET Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions
antibody services. The leading Chinese biotechnology company announced that its services can generate proteins in as little as 3 days and produce antibodies within 7 days, offering a potential step-change
More news about: Beijing Tsingke Biotech Co., Ltd.
Nov 19, 2025, 09:17 ET Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions
antibody services. The leading Chinese biotechnology company announced that its services can generate proteins in as little as 3 days and produce antibodies within 7 days, offering a potential step-change
More news about: Beijing Tsingke Biotech Co., Ltd.
Nov 19, 2025, 09:00 ET ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®
ToolGen (KOSDAQ: 199800) is a biotechnology company focused on developing and commercializing gene-editing platform technologies and applications across human therapeutics, agriculture, and industrial biotechnology. CASGEVY® is a registered trademark
More news about: ToolGen
Nov 19, 2025, 08:48 ET Ventoux Biosciences Launches Research Program Targeting Spinal Cord Injury with VEN-201
SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Ventoux Biosciences, a patient-founded biotechnology company developing therapies for immune-fibrotic diseases, today announced a research program that will explore the therapeutic potential of Ventoux's
More news about: Ventoux Biosciences
Nov 19, 2025, 08:30 ET Process AI in Medical Devices: What Works and What's Next, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Nov 19, 2025, 08:15 ET ExeGi Pharma Launches Visbiome Vet GI Care+ in Canada
been studied in several canine GI concerns. About ExeGi Pharma:ExeGi Pharma LLC is a biotechnology company focused on developing and commercializing live biotherapeutic and probiotic medicines. Our purpose is to formulate the most effective probiotics
More news about: ExeGi Pharma
Nov 19, 2025, 08:06 ET Dalan Animal Health Closes $3M Seed Round via SAFE Financing to Advance Commercialization of First-in-Class Shrimp Vaccine and Expand Platform Applications
About Meach Cove Capital Meach Cove Capital is an investment firm focused on supporting innovative biotechnology companies developing transformative solutions for global health and sustainability challenges. About
More news about: Dalan Animal Health, Inc.
Nov 19, 2025, 07:30 ET Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Nov 19, 2025, 07:08 ET Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery
CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced a non-exclusive
More news about: Nona Biosciences
Nov 19, 2025, 06:59 ET Thin-Film Electrode Market worth $0.97 billion by 2030 - Exclusive Report by MarketsandMarkets™
Chemical Vapor Deposition, Sputtering, Electrochemical Deposition/Electroplating, Other Manufacturing Technology), End-Use Industry (Healthcare & Biotechnology, Electronics & Semiconductor, Energy & Power, Chemical & Petrochemical, Other End-Use Industries) - Global Forecast to 2030", The
More news about: MarketsandMarkets
Nov 19, 2025, 06:45 ET Breakthrough Properties and Eli Lilly and Company Partner to Bring Lilly Gateway Labs to Newly-Developed 2300 Market Street in Philadelphia
around the world and support scientific innovation across biotechnology, agriculture, and nutrition. Breakthrough combines Tishman Speyer's decades of global real estate development experience with Bellco Capital's industry-making biotechnology entrepreneurship to reimagine environments where companies
More news about: Breakthrough Properties
Nov 19, 2025, 06:45 ET Lilly announces plans to open Lilly Gateway Labs site in Philadelphia
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Nov 18, 2025, 14:11 ET Purity Scientific Expands Service Operations into Boston and New England, Strengthening Support for the World's Leading Life Sciences Market
Boston and New England together represent the largest life sciences and biotechnology hub in the world, home to thousands of laboratories spanning academic, clinical, and commercial research. Purity Scientific now provides regional
More news about: Purity Scientific
Nov 18, 2025, 14:05 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
The litigation is focused on the propriety of MoonLake's statements about the trial design and data for SLK. The clinical stage biotechnology company is focused on skin inflammatory diseases driven by a cytokines known as IL-17A and IL-17F. Central to SLK's commercial
More news about: Hagens Berman Sobol Shapiro LLP
Nov 18, 2025, 11:06 ET In-vitro fertilization services in US Market to Reach $8,186.08 Million by 2027 in the short term and $13,944.38 Million by 2032 Globally, at 11.3% CAGR: Allied Market Research
base. With continuous investments in R&D, strong networks of fertility specialists, and growing collaborations between fertility clinics and biotechnology companies, the U.S. infertility services market is set to maintain its leadership position over the forecast period.
More news about: Allied Market Research
Nov 18, 2025, 10:50 ET MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033, Propelled by 8.5% CAGR - Verified Market Reports®
Clinical Laboratories Pharmaceutical Companies Academic Institutions Biotechnology Companies By Technology
More news about: Verified Market Reports
Nov 18, 2025, 10:30 ET Microplastic Analysis Market worth $383.1 million by 2030 with 7.5% CAGR | MarketsandMarkets™
Laboratory Products & Biopharma Services, Analytical Instruments, Life Sciences Solutions, and Specialty Diagnostics, supports pharmaceutical, biotechnology, academic, clinical, environmental, and industrial research. Within microplastic detection, Thermo Fisher's Analytical Instruments division delivers
More news about: MarketsandMarkets